Drugs Made In America Acquisition Corp. DMAA
Nasdaq · XNAS · stock · Blank Checks · website · IPO 2025-01-28
Drugs Made In America Acquisition Corp. statistics & valuation
Market cap$258.3M
P / E43.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 |
|---|---|
| Return on assets | 2.5% |
| Return on equity | -81.8% |
| Current ratio | 0.03 |
Source: SEC EDGAR filings · CIK 0002028614 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.